As an Associate Director in Sanofi’s mRNA Center of Excellence, I am engaged in an exciting quest for clinical acceleration of novel patient-focused mRNA-LNP vaccines, leading efforts to shorten their bench-to-bedside timeline in the context of R&D, analytics, and Phase-1 GMP. A biologist by training, I have extensive expertise in developing and leveraging mRNA-LNP platforms for therapeutic and vaccine applications.